Quick Summary

Jaborandi (Pilocarpus microphyllus) is a medicinal plant primarily valued for its alkaloid pilocarpine. Pilocarpine has been studied mainly for its potential role in managing xerostomia (dry mouth). Current research highlights the need for sustainable use of Jaborandi in the face of environmental challenges and explores the development of topical administration systems to enhance efficacy while possibly reducing systemic adverse effects.

What is it?

Jaborandi is a South American shrub whose leaves contain pilocarpine, an alkaloid compound. Pilocarpine acts as a parasympathomimetic agent and is the main active constituent derived from the plant traditionally used for therapeutic purposes.

Traditional Uses

Traditionally, Jaborandi leaves have been used in herbal medicine to stimulate saliva production and alleviate symptoms related to dry mouth. The plant’s use is also recorded in various indigenous and traditional medicine systems as a natural remedy for related secretory gland dysfunctions.

Active Compounds

The primary active compound in Jaborandi is pilocarpine, an alkaloid known for its cholinergic effects. Pilocarpine stimulates muscarinic receptors, which can promote salivation and other secretory functions.

Potential Benefits with Evidence Levels

  • Management of xerostomia (dry mouth) – Moderate evidence: Several studies report that pilocarpine from Jaborandi improves salivary flow and reduces xerostomia symptoms. Topical administration systems have demonstrated efficacy comparable to oral forms while potentially minimizing systemic side effects (Kapourani et al., 2022).

Side Effects

Oral pilocarpine administration is associated with various adverse effects, including:

  • Sweating
  • Nausea
  • Vomiting
  • Diarrhea
  • Rhinitis
  • Dizziness
  • Increased urinary frequency

Topical delivery methods may reduce these adverse effects and improve tolerance (Kapourani et al., 2022).

Drug Interactions

There are no specific drug interactions documented in the current literature for Jaborandi or its active compound pilocarpine based on the available data.

Who Should Avoid It

While no explicit contraindications have been identified for Jaborandi or pilocarpine, individuals who are pregnant or breastfeeding should avoid use due to insufficient safety data. Caution is also advisable for people with conditions that could be worsened by cholinergic stimulation, although specific guidance is limited.

Evidence Limitations

The evidence predominantly concerns pilocarpine, rather than whole-plant Jaborandi extracts. Clinical research mainly addresses xerostomia, and data on other potential uses are limited. Safety information is chiefly from studies on oral pilocarpine; topical preparations show promise but require further clinical validation. Additional rigorous human clinical trials on the whole plant and broader applications are needed to establish comprehensive safety and efficacy profiles.

References

  • Kapourani A, Kontogiannopoulos KN, Barmpalexis P. A Review on the Role of Pilocarpine on the Management of Xerostomia and the Importance of the Topical Administration Systems Development. 2022. Europe PMC.
    PMC9230966.
  • Mykhailenko O, Jalil B, McGaw LJ, Echeverría J, Takubessi M, Heinrich M. Climate change and the sustainable use of medicinal plants: a call for “new” research strategies. 2024. Europe PMC.
    PMC11830725.
  • Upton R, Agudelo I, Cabrera Y, et al. A U.S. Pharmacopeia (USP) overview of Pan American botanicals used in dietary supplements and herbal medicines. 2024. Europe PMC.
    PMC11392873.
  • Daley SK, Cordell GA. Alkaloids in Contemporary Drug Discovery to Meet Global Disease Needs. 2021. Europe PMC.
    PMC8270272.

Last Reviewed

April 2024

Disclaimer: This content is for informational purposes only and does not constitute medical advice. The use of herbal products should be undertaken cautiously and under the guidance of a qualified healthcare professional. Individual responses to herbal preparations can vary, and safety during pregnancy, breastfeeding, or chronic health conditions has not been firmly established for Jaborandi.